Lupin gets USFDA approval for generic oral contraceptive tablets

05 Nov 2011: Drug maker Lupin has received final approval from the US health regulator to sell its generic version of 'LoSeasonique' tablets, an oral contraceptive drug, in the American market with 180 days of marketing exclusivity.

The approval has been granted to Lupin Pharmaceuticals, the US arm of the company, Lupin said in a statement. The nod by the US Food and Drug Administration (USFDA) is for Levonorgestrel and Ethinyl Estradiol tablets in strengths of 0.1 mg and 0.02 mg and for Ethinyl Estradiol tablets of 0.01 mg, it added. LoSeasonique is patented by Teva Women's Health .

Source: Economic Times